TDC
CTSO icon

Thompson Davis & Co’s Cytosorbents Corp CTSO Stock Holding History

Thompson Davis & Co’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$16K Hold
1,250
– – 0.03% 373
2018
Q2 		$14K Hold
1,250
– – 0.03% 376
2018
Q1 		$9K Buy
1,250
+250
+25% +$1.89K 0.02% 406
2017
Q4 		$7K Hold
1,000
– – 0.02% 466
2017
Q3 		$6K Buy
+1,000
New +$5.1K 0.01% 805

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Thompson Davis & Co's CTSO Position: Q3 2018 in Review

Thompson Davis & Co held its Cytosorbents Corp (CTSO) position steady in Q3 2018 at 1,250 shares worth $16K. The position accounts for 0.03% of the portfolio, ranked #373.

Thompson Davis & Co first reported a position in CTSO in Q3 2017 and has held it in 5 quarters since. 79 funds tracked by Wall St. Rank hold CTSO as of Q3 2018.

  • Thompson Davis & Co held 1,250 shares of Cytosorbents Corp worth $16K as of Q3 2018.
  • Thompson Davis & Co left its Cytosorbents Corp share count unchanged in Q3 2018.
  • Cytosorbents Corp made up 0.03% of Thompson Davis & Co's portfolio in Q3 2018, its #373 holding.
  • Thompson Davis & Co first reported a position in Cytosorbents Corp in Q3 2017 and has held it in 5 quarters since.
  • 79 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.